Correlation Between Esperion Therapeutics and SilverSPAC Unit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and SilverSPAC Unit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and SilverSPAC Unit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and SilverSPAC Unit, you can compare the effects of market volatilities on Esperion Therapeutics and SilverSPAC Unit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of SilverSPAC Unit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and SilverSPAC Unit.

Diversification Opportunities for Esperion Therapeutics and SilverSPAC Unit

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Esperion and SilverSPAC is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and SilverSPAC Unit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SilverSPAC Unit and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with SilverSPAC Unit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SilverSPAC Unit has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and SilverSPAC Unit go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and SilverSPAC Unit

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.04 times less return on investment than SilverSPAC Unit. In addition to that, Esperion Therapeutics is 7.34 times more volatile than SilverSPAC Unit. It trades about 0.0 of its total potential returns per unit of risk. SilverSPAC Unit is currently generating about 0.03 per unit of volatility. If you would invest  1,005  in SilverSPAC Unit on September 3, 2024 and sell it today you would earn a total of  34.00  from holding SilverSPAC Unit or generate 3.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy27.79%
ValuesDaily Returns

Esperion Therapeutics  vs.  SilverSPAC Unit

 Performance 
       Timeline  
Esperion Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
SilverSPAC Unit 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SilverSPAC Unit has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, SilverSPAC Unit is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Esperion Therapeutics and SilverSPAC Unit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Esperion Therapeutics and SilverSPAC Unit

The main advantage of trading using opposite Esperion Therapeutics and SilverSPAC Unit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, SilverSPAC Unit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SilverSPAC Unit will offset losses from the drop in SilverSPAC Unit's long position.
The idea behind Esperion Therapeutics and SilverSPAC Unit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets